Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
01/02/2019 | 23:30 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/06/2018 | 22:30 | GlobeNewswire Inc. | Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
19/06/2018 | 14:00 | GlobeNewswire Inc. | Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with... | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
31/05/2018 | 14:00 | GlobeNewswire Inc. | Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATE... | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
12/03/2018 | 22:18 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
08/03/2018 | 22:27 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
07/03/2018 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
01/03/2018 | 22:10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/02/2018 | 21:50 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/02/2018 | 19:37 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/02/2018 | 19:18 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/02/2018 | 15:16 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
28/02/2018 | 14:55 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
15/02/2018 | 23:31 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
24/01/2018 | 12:11 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
08/01/2018 | 12:13 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (prem14a) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
04/01/2018 | 15:02 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
18/12/2017 | 22:56 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
08/12/2017 | 15:30 | PR Newswire (US) | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entellus Medical, Inc. | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
07/12/2017 | 15:15 | Dow Jones News | Stryker to Buy Entellus Medical For $662 Million | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
07/12/2017 | 14:15 | GlobeNewswire Inc. | Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Shar... | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
14/11/2017 | 22:05 | GlobeNewswire Inc. | Entellus Medical to Participate in Upcoming Investor Conferences | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
13/11/2017 | 11:30 | GlobeNewswire Inc. | Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
03/11/2017 | 21:06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
01/11/2017 | 21:05 | GlobeNewswire Inc. | Entellus Medical Announces Third Quarter 2017 Financial Results | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
30/10/2017 | 13:30 | GlobeNewswire Inc. | Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox® | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
18/10/2017 | 22:05 | GlobeNewswire Inc. | Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017 | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
04/10/2017 | 23:30 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
25/09/2017 | 22:43 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |
25/09/2017 | 22:31 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:ENTL | Entellus Medical, Inc. (delisted) |